GlassScriptPhysician profile
Adam K Cohan
NPI 1982749263
$1,352.94
in general payments reported to CMS, 2019-2025
23 companies · $335 in 2025
The $335 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $204 · 2020: $28.27 · 2021: $29.70 · 2022: $110 · 2023: $410 · 2024: $236 · 2025: $335.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $981.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $981.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $141.06 | 2021-2025 | Slynd, Tyblume |
| Astellas Pharma US INC | $122.77 | 2023-2025 | Veozah |
| Pfizer INC. | $117.40 | 2019-2024 | |
| Organon LLC | $116.55 | 2022-2025 | Nexplanon |
| Coopersurgical, INC. | $90.29 | 2019-2025 | Paragard T 380a, Paragard T 380a |
| Agile Therapeutics, INC. | $84.24 | 2023-2024 | Twirla |
| Mayne Pharma Commercial LLC | $82.01 | 2023-2025 | |
| Abbvie INC. | $75.01 | 2019-2023 | Lo Loestrin Fe, Orilissa |
| Exact Sciences Corporation | $68.96 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Millicent US INC | $67.02 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Gynesonics, INC. | $63.77 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Merck Sharp & Dohme LLC | $54.29 | 2019-2024 | Gardasil, Gardasil 9 |
| Amgen INC. | $44.19 | 2023-2024 | Evenity, Prolia |
| Aspira Women'S Health INC | $40.16 | 2022-2025 | Ova1 |
| Allergan, INC. | $29.85 | 2019 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $27.53 | 2019 | |
| Avion Pharmaceuticals | $24.87 | 2023 | Balcoltra |
| Bayer Healthcare Pharmaceuticals INC. | $24.15 | 2019 | |
| Sumitomo Pharma America, INC. | $19.95 | 2025 | Myfembree |
| Hologic Sales and Service, LLC | $16.31 | 2021 | |
| Therapeuticsmd, INC. | $15.31 | 2020 | |
| Vertical Pharmaceuticals, LLC | $14.29 | 2019 | |
| Mission Pharmacal Company | $12.96 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Cohan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.